See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: June 13, 2007

Cold Sores (Herpes Labialis Infections) Fungal Infections Head and Neck Cancer

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Cold Sores (Herpes Labialis Infections)

This study will evaluate an investigational delivery device and an investigational medication to treat cold sores. Participants must be 18 to 75 with a history of recurrent cold sores in the past year. Compensation of up to $750 is available for time and travel.

The research site is in Dallas, Texas

More information

Please see http://www.centerwatch.com/patient/studies/cat295.html.

-----

Fungal Infections

This study will evaluate an investigational medication for toenail fungus. Participants ages 16-75 will receive all study related exams and investigational medication at no cost, and compensation up to $350 is available for time and travel.

The research site is in Chicago, Ill.

More information

Please see http://www.centerwatch.com/patient/studies/cat66.html.

-----

Head and Neck Cancer

IRX-2 is designed to help your body's immune system better fight head and neck cancers. Volunteers 18-80 who have squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx, and have had no prior surgery (other than biopsy), radiation therapy or chemotherapy of this tumor may be eligible.

The research site is in Charleston, NC.

More information

Please see http://www.centerwatch.com/patient/studies/cat161.html.

-----

Copyright 2007 Thomson CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.